{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T22:29:17Z","timestamp":1759616957624},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,7,23]],"date-time":"2009-07-23T00:00:00Z","timestamp":1248307200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1007\/s00213-009-1617-1","type":"journal-article","created":{"date-parts":[[2009,7,22]],"date-time":"2009-07-22T04:25:28Z","timestamp":1248236728000},"page":"665-676","source":"Crossref","is-referenced-by-count":9,"title":["Serotonergic lesions of the dorsal hippocampus differentially modulate locomotor hyperactivity induced by drugs of abuse in rats: implications for schizophrenia"],"prefix":"10.1007","volume":"206","author":[{"given":"Wendy","family":"Adams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Ayton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten","family":"van den Buuse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,7,23]]},"reference":[{"key":"1617_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1176\/jnp.9.1.1","volume":"9","author":"A Abi-Dargham","year":"1997","unstructured":"Abi-Dargham A, Laruelle M, Aghajanian GK, Charney D, Krystal J (1997) The role of serotonin in the pathophysiology and treatment of schizophrenia. J Neuropsychiatry Clin Neurosci 9:1\u201317","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"1617_CR2","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1523\/JNEUROSCI.18-14-05545.1998","volume":"18","author":"B Adams","year":"1998","unstructured":"Adams B, Moghaddam B (1998) Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J Neurosci 18:5545\u20135554","journal-title":"J Neurosci"},{"key":"1617_CR3","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.neuropharm.2008.06.035","volume":"55","author":"W Adams","year":"2008","unstructured":"Adams W, Kusljic S, van den Buuse M (2008) Serotonin depletion in the dorsal and ventral hippocampus: effects on locomotor hyperactivity, prepulse inhibition and learning and memory. Neuropharmacology 55:1048\u20131055","journal-title":"Neuropharmacology"},{"key":"1617_CR4","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.pharmthera.2006.08.004","volume":"113","author":"KD Alex","year":"2007","unstructured":"Alex KD, Pehek EA (2007) Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol Ther 113:296\u2013320","journal-title":"Pharmacol Ther"},{"key":"1617_CR5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1017\/S1461145705005900","volume":"9","author":"M Amargos-Bosch","year":"2006","unstructured":"Amargos-Bosch M, Lopez-Gil X, Artigas F, Adell A (2006) Clozapine and olanzapine, but not haloperidol, suppress serotonin efflux in the medial prefrontal cortex elicited by phencyclidine and ketamine. Int J Neuropsychopharmacol 9:565\u2013573","journal-title":"Int J Neuropsychopharmacol"},{"key":"1617_CR6","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/cne.902030410","volume":"203","author":"EC Azmitia","year":"1981","unstructured":"Azmitia EC (1981) Bilateral serotonergic projections to the dorsal hippocampus of the rat: simultaneous localization of 3H-5HT and HRP after retrograde transport. J Comp Neurol 203:737\u2013743","journal-title":"J Comp Neurol"},{"key":"1617_CR7","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/cne.901790311","volume":"179","author":"EC Azmitia","year":"1978","unstructured":"Azmitia EC, Segal M (1978) An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J Comp Neurol 179:641\u2013667","journal-title":"J Comp Neurol"},{"key":"1617_CR8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0893-133X(01)00345-1","volume":"26","author":"MG Bankson","year":"2002","unstructured":"Bankson MG, Cunningham KA (2002) Pharmacological studies of the acute effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT1B\/1D and 5-HT2 receptors. Neuropsychopharmacology 26:40\u201352","journal-title":"Neuropsychopharmacology"},{"key":"1617_CR9","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1192\/bjp.111.477.701","volume":"111","author":"DS Bell","year":"1965","unstructured":"Bell DS (1965) Comparison of amphetamine psychosis and schizophrenia. Br J Psychiatry 111:701\u2013707","journal-title":"Br J Psychiatry"},{"key":"1617_CR10","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ejphar.2008.04.046","volume":"588","author":"JP Capela","year":"2008","unstructured":"Capela JP, Lautenschlager M, Dirnagl U, Bastos ML, Carvalho F, Meisel A (2008) 5,7-Dihydroxitryptamine toxicity to serotonergic neurons in serum free raphe cultures. Eur J Pharmacol 588:232\u2013238","journal-title":"Eur J Pharmacol"},{"key":"1617_CR11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0006-3223(01)01134-9","volume":"50","author":"RA Chambers","year":"2001","unstructured":"Chambers RA, Krystal JH, Self DW (2001) A neurobiological basis for substance abuse comorbidity in schizophrenia. Biol Psychiatry 50:71\u201383","journal-title":"Biol Psychiatry"},{"key":"1617_CR12","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/sj.npp.1300678","volume":"30","author":"EH Chartoff","year":"2005","unstructured":"Chartoff EH, Heusner CL, Palmiter RD (2005) Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists. Neuropsychopharmacology 30:1324\u20131333","journal-title":"Neuropsychopharmacology"},{"key":"1617_CR13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0091-3057(94)90506-1","volume":"48","author":"W Danysz","year":"1994","unstructured":"Danysz W, Essmann U, Bresink I, Wilke R (1994) Glutamate antagonists have different effects on spontaneous locomotor activity in rats. Pharmacol Biochem Behav 48:111\u2013118","journal-title":"Pharmacol Biochem Behav"},{"key":"1617_CR14","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.brainresrev.2005.09.002","volume":"50","author":"HN David","year":"2005","unstructured":"David HN, Ansseau M, Abraini JH (2005) Dopamine\u2013glutamate reciprocal modulation of release and motor responses in the rat caudate-putamen and nucleus accumbens of \u201cintact\u201d animals. Brain Res Brain Res Rev 50:336\u2013360","journal-title":"Brain Res Brain Res Rev"},{"key":"1617_CR15","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1176\/ajp.148.11.1474","volume":"148","author":"KL Davis","year":"1991","unstructured":"Davis KL, Kahn RS, Ko G, Davidson M (1991) Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 148:1474\u20131486","journal-title":"Am J Psychiatry"},{"key":"1617_CR16","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","volume":"85","author":"G Chiara Di","year":"1988","unstructured":"Di Chiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 85:5274\u20135278","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1617_CR17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0006-8993(99)01776-X","volume":"843","author":"GE Duncan","year":"1999","unstructured":"Duncan GE, Miyamoto S, Leipzig JN, Lieberman JA (1999) Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine. Brain Res 843:171\u2013183","journal-title":"Brain Res"},{"key":"1617_CR18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1566-2772(03)00022-7","volume":"3","author":"JH Fallon","year":"2003","unstructured":"Fallon JH, Opole IO, Potkin SG (2003) The neuroanatomy of schizophrenia: circuitry and neurotransmitter systems. Clin Neurosci Res 3:77\u2013107","journal-title":"Clin Neurosci Res"},{"key":"1617_CR19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1196\/annals.1300.008","volume":"1003","author":"NB Farber","year":"2003","unstructured":"Farber NB (2003) The NMDA receptor hypofunction model of psychosis. Ann N Y Acad Sci 1003:119\u2013130","journal-title":"Ann N Y Acad Sci"},{"key":"1617_CR20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/bjp.2008.51","volume":"154","author":"MW Feltenstein","year":"2008","unstructured":"Feltenstein MW, See RE (2008) The neurocircuitry of addiction: an overview. Br J Pharmacol 154:261\u2013274","journal-title":"Br J Pharmacol"},{"key":"1617_CR21","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1124\/jpet.104.068841","volume":"310","author":"M Filip","year":"2004","unstructured":"Filip M, Bubar MJ, Cunningham KA (2004) Contribution of serotonin (5-hydroxytryptamine; 5-HT) 5-HT2 receptor subtypes to the hyperlocomotor effects of cocaine: acute and chronic pharmacological analyses. J Pharmacol Exp Ther 310:1246\u20131254","journal-title":"J Pharmacol Exp Ther"},{"key":"1617_CR22","first-page":"576","volume":"27","author":"PJ Fletcher","year":"2002","unstructured":"Fletcher PJ, Grottick AJ, Higgins GA (2002) Differential effects of the 5-HT2A receptor antagonist M100907 and the 5-HT2C receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding. Neuropsychopharmacology 27:576\u2013586","journal-title":"Neuropsychopharmacology"},{"key":"1617_CR23","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bbr.2009.01.036","volume":"201","author":"PJ Fletcher","year":"2009","unstructured":"Fletcher PJ, Chambers JW, Rizos Z, Chintoh AF (2009) Effects of 5-HT depletion in the frontal cortex or nucleus accumbens on response inhibition measured in the 5-choice serial reaction time test and on a DRL schedule. Behav Brain Res 201:88\u201398","journal-title":"Behav Brain Res"},{"key":"1617_CR24","first-page":"787","volume-title":"Psychopharmacology: the fourth generation of progress","author":"MA Geyer","year":"1995","unstructured":"Geyer MA, Markou A (1995) Animal models of psychiatric disorders. In: Bloom F, Kupfer D (eds) Psychopharmacology: the fourth generation of progress. Raven, New York, pp 787\u2013798"},{"key":"1617_CR25","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.tins.2008.08.002","volume":"31","author":"Y Goto","year":"2008","unstructured":"Goto Y, Grace AA (2008) Limbic and cortical information processing in the nucleus accumbens. Trends Neurosci 31:552\u2013558","journal-title":"Trends Neurosci"},{"key":"1617_CR26","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0165-0173(99)00049-1","volume":"31","author":"AA Grace","year":"2000","unstructured":"Grace AA (2000) Gating of information flow within the limbic system and the pathophysiology of schizophrenia. Brain Res Brain Res Rev 31:330\u2013341","journal-title":"Brain Res Brain Res Rev"},{"key":"1617_CR27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00213-003-1761-y","volume":"174","author":"PJ Harrison","year":"2004","unstructured":"Harrison PJ (2004) The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology (Berl) 174:151\u2013162","journal-title":"Psychopharmacology (Berl)"},{"key":"1617_CR28","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1523\/JNEUROSCI.3800-04.2005","volume":"25","author":"MJ Hunt","year":"2005","unstructured":"Hunt MJ, Kessal K, Garcia R (2005) Ketamine induces dopamine-dependent depression of evoked hippocampal activity in the nucleus accumbens in freely moving rats. J Neurosci 25:524\u2013531","journal-title":"J Neurosci"},{"key":"1617_CR29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","volume":"20","author":"JD Jentsch","year":"1999","unstructured":"Jentsch JD, Roth RH (1999) The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20:201\u2013225","journal-title":"Neuropsychopharmacology"},{"key":"1617_CR30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1146\/annurev.ne.03.030180.001125","volume":"3","author":"G Jonsson","year":"1980","unstructured":"Jonsson G (1980) Chemical neurotoxins as denervation tools in neurobiology. Annu Rev Neurosci 3:169\u2013187","journal-title":"Annu Rev Neurosci"},{"key":"1617_CR31","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2165\/00003495-200262050-00003","volume":"62","author":"DJ Kavanagh","year":"2002","unstructured":"Kavanagh DJ, McGrath J, Saunders JB, Dore G, Clark D (2002) Substance misuse in patients with schizophrenia: epidemiology and management. Drugs 62:743\u2013755","journal-title":"Drugs"},{"key":"1617_CR32","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/0306-4522(82)90198-1","volume":"7","author":"AE Kelley","year":"1982","unstructured":"Kelley AE, Domesick VB (1982) The distribution of the projection from the hippocampal formation to the nucleus accumbens in the rat: an anterograde- and retrograde-horseradish peroxidase study. Neuroscience 7:2321\u20132335","journal-title":"Neuroscience"},{"key":"1617_CR33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0014-2999(76)90352-6","volume":"40","author":"PH Kelly","year":"1976","unstructured":"Kelly PH, Iversen SD (1976) Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats. Eur J Pharmacol 40:45\u201356","journal-title":"Eur J Pharmacol"},{"key":"1617_CR34","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0006-8993(75)90233-4","volume":"94","author":"PH Kelly","year":"1975","unstructured":"Kelly PH, Seviour PW, Iversen SD (1975) Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res 94:507\u2013522","journal-title":"Brain Res"},{"key":"1617_CR35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0165-6147(92)90060-J","volume":"13","author":"GF Koob","year":"1992","unstructured":"Koob GF (1992) Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13:177\u2013184","journal-title":"Trends Pharmacol Sci"},{"key":"1617_CR36","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","volume":"51","author":"JH Krystal","year":"1994","unstructured":"Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr, Charney DS (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51:199\u2013214","journal-title":"Arch Gen Psychiatry"},{"key":"1617_CR37","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1111\/j.1460-9568.2004.03804.x","volume":"20","author":"S Kusljic","year":"2004","unstructured":"Kusljic S, van den Buuse M (2004) Functional dissociation between serotonergic pathways in dorsal and ventral hippocampus in psychotomimetic drug-induced locomotor hyperactivity and prepulse inhibition in rats. Eur J NeuroSci 20:3424\u20133432","journal-title":"Eur J NeuroSci"},{"key":"1617_CR38","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s00213-006-0344-0","volume":"186","author":"CL Littlewood","year":"2006","unstructured":"Littlewood CL, Jones N, O'Neill MJ, Mitchell SN, Tricklebank M, Williams SC (2006) Mapping the central effects of ketamine in the rat using pharmacological MRI. Psychopharmacology (Berl) 186:64\u201381","journal-title":"Psychopharmacology (Berl)"},{"key":"1617_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-4328(00)00138-8","volume":"111","author":"J Ma","year":"2000","unstructured":"Ma J, Leung LS (2000) Relation between hippocampal gamma waves and behavioral disturbances induced by phencyclidine and methamphetamine. Behav Brain Res 111:1\u201311","journal-title":"Behav Brain Res"},{"key":"1617_CR40","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0006-8993(98)00165-6","volume":"793","author":"J Ma","year":"1998","unstructured":"Ma J, Brudzynski SM, Leung LW (1998) A role of subicular and hippocampal afterdischarges in initiation of locomotor activity in rats. Brain Res 793:112\u2013118","journal-title":"Brain Res"},{"key":"1617_CR41","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0893-133X(97)00036-5","volume":"17","author":"AK Malhotra","year":"1997","unstructured":"Malhotra AK, Pinals DA, Adler CM, Elman I, Clifton A, Pickar D, Breier A (1997) Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology 17:141\u2013150","journal-title":"Neuropsychopharmacology"},{"key":"1617_CR42","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0893-133X(98)00087-6","volume":"20","author":"AC McCreary","year":"1999","unstructured":"McCreary AC, Cunningham KA (1999) Effects of the 5-HT2C\/2B antagonist SB 206553 on hyperactivity induced by cocaine. Neuropsychopharmacology 20:556\u2013564","journal-title":"Neuropsychopharmacology"},{"key":"1617_CR43","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/hipo.1070","volume":"11","author":"DR Medoff","year":"2001","unstructured":"Medoff DR, Holcomb HH, Lahti AC, Tamminga CA (2001) Probing the human hippocampus using rCBF: contrasts in schizophrenia. Hippocampus 11:543\u2013550","journal-title":"Hippocampus"},{"key":"1617_CR44","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0301-0082(80)90018-0","volume":"14","author":"GJ Mogenson","year":"1980","unstructured":"Mogenson GJ, Jones DL, Yim CY (1980) From motivation to action: functional interface between the limbic system and the motor system. Prog Neurobiol 14:69\u201397","journal-title":"Prog Neurobiol"},{"key":"1617_CR45","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1126\/science.281.5381.1349","volume":"281","author":"B Moghaddam","year":"1998","unstructured":"Moghaddam B, Adams BW (1998) Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281:1349\u20131352","journal-title":"Science"},{"key":"1617_CR46","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","volume":"17","author":"B Moghaddam","year":"1997","unstructured":"Moghaddam B, Adams B, Verma A, Daly D (1997) Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17:2921\u20132927","journal-title":"J Neurosci"},{"key":"1617_CR47","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1213\/01.ane.0000255200.42574.22","volume":"104","author":"K Mukaida","year":"2007","unstructured":"Mukaida K, Shichino T, Koyanagi S, Himukashi S, Fukuda K (2007) Activity of the serotonergic system during isoflurane anesthesia. Anesth Analg 104:836\u2013839","journal-title":"Anesth Analg"},{"key":"1617_CR48","volume-title":"Australian code of practice for the care and use of animals for scientific purposes","author":"National Health and Medical Research Council of Australia","year":"1990","unstructured":"National Health and Medical Research Council of Australia (1990) Australian code of practice for the care and use of animals for scientific purposes. Australian Government Publishing Services, Canberra"},{"key":"1617_CR49","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0022-3956(99)00029-1","volume":"33","author":"JW Olney","year":"1999","unstructured":"Olney JW, Newcomer JW, Farber NB (1999) NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res 33:523\u2013533","journal-title":"J Psychiatr Res"},{"key":"1617_CR50","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF00432674","volume":"74","author":"R Ortmann","year":"1981","unstructured":"Ortmann R, Martin S, Waldmeier PC (1981) Supersensitivity to L-5-hydroxytryptophan after 5,7-dihydroxytryptamine injections in desmethylimipramine- and nomifensine-pretreated rats: behavioral evidence for postsynaptic supersensitivity. Psychopharmacology (Berl) 74:109\u2013114","journal-title":"Psychopharmacology (Berl)"},{"key":"1617_CR51","volume-title":"The rat brain in stereotaxic co-ordinates","author":"G Paxinos","year":"1998","unstructured":"Paxinos G, Watson C (1998) The rat brain in stereotaxic co-ordinates, 4th edn. Academic Press, San Diego","edition":"4"},{"key":"1617_CR52","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0014-2999(76)90299-5","volume":"35","author":"AJ Pijnenburg","year":"1976","unstructured":"Pijnenburg AJ, Honig WM, Van der Heyden JA, Van Rossum JM (1976) Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity. Eur J Pharmacol 35:45\u201358","journal-title":"Eur J Pharmacol"},{"key":"1617_CR53","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1176\/ajp.132.3.225","volume":"132","author":"RM Post","year":"1975","unstructured":"Post RM (1975) Cocaine psychoses: a continuum model. Am J Psychiatry 132:225\u2013231","journal-title":"Am J Psychiatry"},{"key":"1617_CR54","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/sj.npp.1301057","volume":"32","author":"F Razoux","year":"2007","unstructured":"Razoux F, Garcia R, Lena I (2007) Ketamine, at a dose that disrupts motor behavior and latent inhibition, enhances prefrontal cortex synaptic efficacy and glutamate release in the nucleus accumbens. Neuropsychopharmacology 32:719\u2013727","journal-title":"Neuropsychopharmacology"},{"key":"1617_CR55","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejphar.2003.08.054","volume":"479","author":"RB Rothman","year":"2003","unstructured":"Rothman RB, Baumann MH (2003) Monoamine transporters and psychostimulant drugs. Eur J Pharmacol 479:23\u201340","journal-title":"Eur J Pharmacol"},{"key":"1617_CR56","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/00000542-200503000-00021","volume":"102","author":"K Semba","year":"2005","unstructured":"Semba K, Adachi N, Arai T (2005) Facilitation of serotonergic activity and amnesia in rats caused by intravenous anesthetics. Anesthesiology 102:616\u2013623","journal-title":"Anesthesiology"},{"key":"1617_CR57","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00213-002-1288-7","volume":"165","author":"JR Shoblock","year":"2003","unstructured":"Shoblock JR, Sullivan EB, Maisonneuve IM, Glick SD (2003) Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats. Psychopharmacology (Berl) 165:359\u2013369","journal-title":"Psychopharmacology (Berl)"},{"key":"1617_CR58","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1080\/j.1440-1614.2005.01626.x","volume":"39","author":"M Buuse van den","year":"2005","unstructured":"van den Buuse M, Garner B, Gogos A, Kusljic S (2005) Importance of animal models in schizophrenia research. Aust NZ J Psychiatry 39:550\u2013557","journal-title":"Aust NZ J Psychiatry"},{"key":"1617_CR59","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/0306-4522(80)90088-3","volume":"5","author":"I Walaas","year":"1980","unstructured":"Walaas I, Fonnum F (1980) Biochemical evidence for glutamate as a transmitter in hippocampal efferents to the basal forebrain and hypothalamus in the rat brain. Neuroscience 5:1691\u20131698","journal-title":"Neuroscience"},{"key":"1617_CR60","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1213\/01.ane.0000221488.48352.61","volume":"103","author":"RA Whittington","year":"2006","unstructured":"Whittington RA, Virag L (2006) Isoflurane decreases extracellular serotonin in the mouse hippocampus. Anesth Analg 103:92\u201398","journal-title":"Anesth Analg"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-009-1617-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-009-1617-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-009-1617-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T16:07:03Z","timestamp":1558627623000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-009-1617-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,23]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["1617"],"URL":"https:\/\/doi.org\/10.1007\/s00213-009-1617-1","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,23]]}}}